Sotera Health Company logo

Sotera Health Company (SHC)

Market Closed
24 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
16. 72
-0.77
-4.4%
$
4.97B Market Cap
60.83 P/E Ratio
- Div Yield
2,601,826 Volume
0.71 Eps
$ 17.49
Previous Close
Day Range
16.6 17.87
Year Range
9.53 19.85
Want to track SHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SHC earnings report is expected in 1 days (26 Feb 2026)
Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 9 months ago
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates

Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago.

Zacks | 9 months ago
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?

Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?

Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately.

Zacks | 10 months ago
Sotera Health Has A Great Deleveraging Path Ahead

Sotera Health Has A Great Deleveraging Path Ahead

Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging.

Seekingalpha | 10 months ago
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript

Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript

Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call.

Seekingalpha | 0 year ago
Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 0 year ago
Sotera Health Company (SHC) Meets Q4 Earnings Estimates

Sotera Health Company (SHC) Meets Q4 Earnings Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago.

Zacks | 0 year ago
Insights Into Sotera Health (SHC) Q4: Wall Street Projections for Key Metrics

Insights Into Sotera Health (SHC) Q4: Wall Street Projections for Key Metrics

Evaluate the expected performance of Sotera Health (SHC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks | 1 year ago
Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript

Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript

Sotera Health Company (NASDAQ:SHC ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Sean Dodge - RBC Capital Markets Patrick Donnelly - Citigroup Inc. Salem Salem - Barclays Brett Fishbin - KeyBanc Capital Markets Casey Woodring - J.P. Morgan Chase Jason Bednar - Piper Sandler Dave Windley - Jefferies Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Third Quarter 2024 Conference Call.

Seekingalpha | 1 year ago
Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Sotera Health Company (SHC) Q3 Earnings Lag Estimates

Sotera Health Company (SHC) Q3 Earnings Lag Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.21 per share a year ago.

Zacks | 1 year ago
Analysts Estimate Sotera Health Company (SHC) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Sotera Health Company (SHC) to Report a Decline in Earnings: What to Look Out for

Sotera Health (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Loading...
Load More